AUG 14, 2026 · INTERVENTIONAL STUDY
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
ClinicalTrials.gov
This is a recruiting, uncontrolled, single-arm phase-agnostic safety and dose-escalation study with no published results; it is exploratory work in a novel intervention.
Reported
Estimated enrollment30
Primary outcome measureIncremental increase of NTP dose to reach m…
Follow-up duration3 months